Journal ArticleOPEN ACCESS

Breakthrough fungal infections in patients with leukemia receiving isavuconazole

Clinical Infectious Diseases (2018) 67(10) 1610-1613
DOI: 10.1093/cid/ciy406
104Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

Abstract

We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.

Author supplied keywords

Cite

CITATION STYLE

APA

Rausch, C. R., Dipippo, A. J., Bose, P., & Kontoyiannis, D. P. (2018). Breakthrough fungal infections in patients with leukemia receiving isavuconazole. Clinical Infectious Diseases, 67(10), 1610–1613. https://doi.org/10.1093/cid/ciy406

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free